サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1338972

小児けいれん治療薬市場、シェア、規模、動向、産業分析レポート：治療薬クラス別；治療薬タイプ別；調剤別、投与経路別；流通経路別；地域別2023年～2032年

Infantile Spasm Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Class (Anticonvulsants, Corticosteroids, Others); By Drug Type; By Dosage, By Route of Administration; By Distribution Channel; and Region 2023 - 2032

出版日
ページ情報
英文 117 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
小児けいれん治療薬市場、シェア、規模、動向、産業分析レポート：治療薬クラス別；治療薬タイプ別；調剤別、投与経路別；流通経路別；地域別2023年～2032年
出版日: 2023年06月23日
発行: Polaris Market Research
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、小児けいれん治療薬の市場規模は2032年までに1億8,185万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

市場は、ジェネリック医薬品を含む画期的な医薬品開拓を示しています。例えば、MSN Labs社はインド初のビガバトリンのジェネリック医薬品（ビガネクスト）を発売し、これは粉末として投与されます。最近の技術的進歩は、特に小児けいれん治療薬の事前治療薬と予防治療薬において顕著であり、例えば、発作の早期発見に役立つ非侵襲的自動発作検出装置の開発により、この障害を治療薬するためのより良いソリューションが提供されています。COVID-19の時代に、遠隔医療と遠隔相談の存在により、小児けいれん治療薬市場は、監禁の時代に広く使用されたため、急増を見ました。この巨大な需要は、簡単で快適な検診、世界中からの相談などの利点のために見られました。

世界中で毎年12月の第1週に行われる「小児けいれん治療薬啓発週間」のような啓発キャンペーンが存在し、増加していることは、市場にプラスの影響を与えることに貢献しています。また、研究開発に関連する投資が集中し、新薬開発の増加につながることで、新規かつ適合性の高い医薬品への需要が高まっています。世界銀行のデータによると、世界のGDPの2.63%が、市場で入手可能な治療薬のより良い代替品の研究開発に投資されています。

小児けいれん治療薬市場レポートハイライト

抗けいれん薬が最大の売上シェアを占める。これは、高い有効性と治療薬中の患者における忍容性の容易さによるものです。

副腎皮質刺激ホルモンセグメントは、その安全性と有効性により、小児けいれん治療薬として臨床医や処方者に好まれているため、最大の売上シェアを占めています。

小児患者への投与が容易、患者のコンプライアンスが高い、作用発現が早いなどの利点から、液剤セグメントが最大の市場シェアを占めています。

病院セグメンテーションは、小児けいれん治療薬には医師の立会いが必要であること、病院薬局は他の流通形態に比べて利便性が高いことから、最大の市場シェアを占めています。

北米が市場を独占しているのは、技術が早くから受け入れられ、ヘルスケアのインフラがより良く整備され、製品のイノベーションが常に推進されているからです。

市場の主なプレーヤーには、Lundbeck社、Mallinckrodt Pharmaceuticals社、マーケットカタリスト・ファーマシューティカルズ社、GWファーマシューティカルズ社、Retrophin社、Valerion Therapeutics社、Orphelia Pharma社、Insys Therapeutics社、Anavex Life Sciences社などがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の小児けいれん治療薬市場に関する洞察

  • 小児けいれん治療薬- 業界スナップショット
  • 小児けいれん治療薬市場力学
    • 促進要因と機会
      • 新生児における小児けいれんの発生率の増加
      • 政府の支援を増やす
    • 抑制要因と課題
      • 高額な治療薬費
  • PESTLE分析
  • 小児けいれん治療薬業界の動向
  • COVID-19感染症の影響分析

第5章 世界の小児けいれん治療薬市場、治療薬クラス別

  • 主な調査結果
  • イントロダクション
  • 抗けいれん薬
  • コルチコステロイド
  • その他

第6章 世界の小児けいれん治療薬市場、治療薬タイプ別

  • 主な調査結果
  • イントロダクション
  • ビガバトリン
  • 副腎皮質刺激ホルモン
  • その他（フェーズⅢ）

第7章 世界の小児けいれん治療薬市場、調剤別

  • 主な調査結果
  • イントロダクション
  • 固体
  • 液体

第8章 世界の小児けいれん治療薬市場、投与経路別

  • 主な調査結果
  • イントロダクション
  • 経口
  • 非経口
  • その他

第9章 世界の小児けいれん治療薬市場、流通チャネル別

  • 主な調査結果
  • イントロダクション
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第10章 世界の小児けいれん治療薬市場、地域別

  • 主な調査結果
  • イントロダクション
    • 小児けいれん治療薬市場評価、地域別、2019～2032年
  • 小児けいれん治療薬市場-北米
    • 北米：小児けいれん治療薬市場、治療薬クラス別、2019～2032年
    • 北米：小児けいれん治療薬市場、投与経路別、2019～2032年
    • 北米：小児けいれん治療薬市場、治療薬タイプ別、2019～2032年
    • 北米：小児けいれん治療薬市場、調剤別、2019～2032年
    • 北米：小児けいれん治療薬市場、流通チャネル別、2019～2032年
    • 小児けいれん治療薬市場-米国
    • 小児けいれん治療薬市場- カナダ
  • 小児けいれん治療薬市場- 欧州
    • 欧州：小児けいれん治療薬市場、治療薬クラス別、2019～2032年
    • 欧州：小児けいれん治療薬市場、投与経路別、2019～2032年
    • 欧州：小児けいれん治療薬市場、治療薬タイプ別、2019～2032年
    • 欧州：小児けいれん治療薬市場、調剤別、2019～2032年
    • 欧州：小児けいれん治療薬市場、流通チャネル別、2019～2032年
    • 小児けいれん治療薬市場- 英国
    • 小児けいれん治療薬市場- フランス
    • 小児けいれん治療薬市場- ドイツ
    • 小児けいれん治療薬市場- イタリア
    • 小児けいれん治療薬市場- スペイン
    • 小児けいれん治療薬市場- オランダ
    • 小児けいれん治療薬市場- ロシア
  • 小児けいれん治療薬市場- アジア太平洋
    • アジア太平洋：小児けいれん治療薬市場、治療薬クラス別、2019～2032年
    • アジア太平洋：小児けいれん治療薬市場、投与経路別、2019～2032年
    • アジア太平洋：小児けいれん治療薬市場、治療薬タイプ別、2019～2032年
    • アジア太平洋：小児けいれん治療薬市場、調剤別、2019～2032年
    • アジア太平洋：小児けいれん治療薬市場、流通チャネル別、2019～2032年
    • 小児けいれん治療薬市場- 中国
    • 小児けいれん治療薬市場- インド
    • 小児けいれん治療薬市場- 日本
    • 小児けいれん治療薬市場- マレーシア
    • 小児けいれん治療薬市場- インドネシア
    • 小児けいれん治療薬市場- 韓国
  • 小児けいれん治療薬市場-中東およびアフリカ
    • 中東およびアフリカ：小児けいれん治療薬市場、治療薬クラス別、2019～2032年
    • 中東およびアフリカ：小児けいれん治療薬市場、投与経路別、2019～2032年
    • 中東およびアフリカ：小児けいれん治療薬市場、治療薬タイプ別、2019～2032年
    • 中東およびアフリカ：小児けいれん治療薬市場、調剤別、2019～2032年
    • 中東およびアフリカ：小児けいれん治療薬市場、流通チャネル別、2019～2032年
    • 小児けいれん治療薬市場- サウジアラビア
    • 小児けいれん治療薬市場- アラブ首長国連邦
    • 小児けいれん治療薬市場- イスラエル
    • 小児けいれん治療薬市場- 南アフリカ
  • 小児けいれん治療薬市場-ラテンアメリカ
    • ラテンアメリカ：小児けいれん治療薬市場、治療薬クラス別、2019～2032年
    • ラテンアメリカ：小児けいれん治療薬市場、投与経路別、2019～2032年
    • ラテンアメリカ：小児けいれん治療薬市場、治療薬タイプ別、2019～2032年
    • ラテンアメリカ：小児けいれん治療薬市場、調剤別、2019～2032年
    • ラテンアメリカ：小児けいれん治療薬市場、流通チャネル別、2019～2032年
    • 小児けいれん治療薬市場- メキシコ
    • 小児けいれん治療薬市場- ブラジル
    • 小児けいれん治療薬市場- アルゼンチン

第11章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第12章 企業プロファイル

  • Lundbeck
  • Mallinckrodt Pharmaceuticals
  • Catalyst Pharmaceuticals
  • GW Pharmaceuticals
  • Retrophin
  • Valerion Therapeutics
  • Orphelia Pharma
  • Insys Therapeutics
  • Anavex Life Sciences Corp
図表

List of Tables

  • Table 1 Global Infantile Spasm Therapeutics Market, by Therapeutic Class, by Region, 2019-2032 (USD Million)
  • Table 2 Global Infantile Spasm Therapeutics Market, by Drug Type, by Region, 2019-2032 (USD Million)
  • Table 3 Global Infantile Spasm Therapeutics Market, by Dosage, by Region, 2019-2032 (USD Million)
  • Table 4 Global Infantile Spasm Therapeutics Market, by Distribution Channel, by Region, 2019-2032 (USD Million)
  • Table 5 Global Infantile Spasm Therapeutics Market, by Route of Administration, by Region, 2019-2032 (USD Million)
  • Table 6 North America: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 7 North America: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 8 North America: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 9 North America: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 10 North America: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 11 U.S.: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 12 U.S.: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 13 U.S.: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 14 U.S.: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 15 U.S.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 16 Canada: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 17 Canada: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 18 Canada: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 19 Canada: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 20 Canada: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 21 Europe: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 22 Europe: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 23 Europe: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 24 Europe: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 25 Europe: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 26 Germany: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 27 Germany: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 28 Germany: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 29 Germany: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 30 Germany: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 31 France: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 32 France: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 33 France: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 34 France: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 35 France: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 36 UK: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 37 UK: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 38 UK: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 39 UK: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 40 UK: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 41 Italy: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 42 Italy: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 43 Italy: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 44 Italy: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 45 Italy: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 46 Netherlands: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 47 Netherlands: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 48 Netherlands: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 49 Netherlands: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 50 Netherlands: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 51 Spain: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 52 Spain: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 53 Spain: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 54 Spain: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 55 Spain: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 56 Russia: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 57 Russia: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 58 Russia: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 59 Russia: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 60 Russia: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 61 Asia Pacific: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 62 Asia Pacific: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 63 Asia Pacific: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 64 Asia Pacific: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 65 Asia Pacific: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 66 China: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 67 China: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 68 China: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 69 China: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 70 China: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 71 Japan: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 72 Japan: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 73 Japan: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 74 Japan: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 75 Japan: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 76 India: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 77 India: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 78 India: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 79 India: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 80 India: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 81 Indonesia: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 82 Indonesia: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 83 Indonesia: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 84 Indonesia: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 85 Indonesia: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 86 Malaysia: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 87 Malaysia: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 88 Malaysia: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 89 Malaysia: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 90 Malaysia: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 91 South Korea: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 92 South Korea: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 93 South Korea: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 94 South Korea: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 95 South Korea: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 96 Latin America: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 97 Latin America: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 98 Latin America: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 99 Latin America: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 100 Latin America: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 101 Brazil: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 102 Brazil: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 103 Brazil: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 104 Brazil: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 105 Brazil: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 106 Mexico: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 107 Mexico: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 108 Mexico: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 109 Mexico: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 110 Mexico: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 111 Argentina: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 112 Argentina: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 113 Argentina: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 114 Argentina: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 115 Argentina: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 116 Middle East & Africa: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 117 Middle East & Africa: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 118 Middle East & Africa: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 119 Middle East & Africa: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 120 Middle East & Africa: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 121 UAE: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 122 UAE: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 123 UAE: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 124 UAE: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 125 UAE: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 126 Saudi Arabia: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 127 Saudi Arabia: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 128 Saudi Arabia: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 129 Saudi Arabia: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 130 Saudi Arabia: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 131 South Africa: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 132 South Africa: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 133 South Africa: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 134 South Africa: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 135 South Africa: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 136 Israel: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • Table 137 Israel: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • Table 138 Israel: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • Table 139 Israel: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 140 Israel: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Infantile Spasm Therapeutics Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Therapeutic Class
  • Figure 7. Global Infantile Spasm Therapeutics Market, by Therapeutic Class, 2021 & 2030 (USD Million)
  • Figure 8. Market by Drug Type
  • Figure 9. Global Infantile Spasm Therapeutics Market, by Drug Type, 2021 & 2030 (USD Million)
  • Figure 10. Market by Dosage
  • Figure 11. Global Infantile Spasm Therapeutics Market, by Dosage, 2021 & 2030 (USD Million)
  • Figure 12. Market by Distribution Channel
  • Figure 13. Global Infantile Spasm Therapeutics Market, by Distribution Channel, 2021 & 2030 (USD Million)
  • Figure 14. Market by Route of Administration
  • Figure 15. Global Infantile Spasm Therapeutics Market, by Route of Administration, 2021 & 2030 (USD Million)
目次
Product Code: PM3416

The infantile spasm therapeutics market size is expected to reach USD 181.85 million by 2032, according to a new study by Polaris Market Research. The report "Infantile Spasm Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Class (Anticonvulsants, Corticosteroids, Others); By Drug Type; By Dosage, By Route of Administration; By Distribution Channel; and Region 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Market has witnessed some revolutionary drug developments including generic drugs, for e.g., MSN Labs launched India's first generic Vigabatrin (Viganext) that is to be administered as a powder. The recent technological advancements particularly in advance treatment and preventive treatment of Infantile Spasm Therapeutics, like development of non-invasive automated seizure detection device that help in early detection of seizure to provide better solutions for to treat the disorder. Due to presence of telemedicine and teleconsultation, during the times of COVID-19, Infantile Spasm Therapeutics market has seen a jump as it was widely used during the times of lockdown. This huge demand was seen due to the advantages of easy and comfortable check-up, consultation from across the globe amongst others.

The presence and increase of awareness campaigns like that of Infantile Spasm Therapeutics Awareness Week every first week of December across the globe contribute to positively impacting the market. Also, the growing demand for novel and compliant drugs is made possible by an increasing concentration on investments associated to research and development, which leads to an increase in new drug development. According to World Bank data, 2.63% of global GDP is invested in research and development of better alternatives to the drugs available in the market.

Infantile Spasm Therapeutics Market Report Highlights

The anticonvulsants segment accounted for the largest revenue share. This is due to its higher efficacy and ease of tolerance in patients undergoing treatment

Adrenocorticotropic hormone segment accounted to hold largest revenue share as it is preferred by the clinicians and prescribers to treat Infantile Spasm Therapeutics owing to its safety and efficacy making it the drug of choice

Liquid segment accounted for largest market share due to its advantages like ease of administration in infantile patients, high patient compliance, and rapid onset of action

Hospital Pharmacy segment account for a largest market share owing to the reason that Infantile Spasm Therapeutics requires treatment in presence of a medical practitioner and, hospital pharmacies provide convenience as compared to other modes of distribution

North America dominated the market as there is more early acceptance of techniques, better and more developed healthcare infrastructure and constant drive for product innovation.

The major players in the market include Lundbeck, Mallinckrodt Pharmaceuticals, Catalyst Pharmaceuticals, GW Pharmaceuticals, Retrophin, Valerion Therapeutics, Orphelia Pharma, Insys Therapeutics, & Anavex Life Sciences.

Polaris Market Research has segmented the Infantile Spasm Therapeutics market report based on therapeutic class, dosage, route of administration, distribution channel, drug type, and region:

Infantile Spasm Therapeutics Market, Therapeutic Class Outlook (Revenue - USD Million, 2019 - 2032)

  • Anticonvulsants
  • Corticosteroids
  • Others

Infantile Spasm Therapeutics Market, Drug Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Vigabatrin
  • Adrenocorticotropic Hormone
  • Others (Phase III)

Infantile Spasm Therapeutics Market, Dosage Outlook (Revenue - USD Million, 2019 - 2032)

  • Solid
  • Liquid

Infantile Spasm Therapeutics Market, Route of Administration Outlook (Revenue - USD Million, 2019 - 2032)

  • Oral
  • Parenteral
  • Others

Infantile Spasm Therapeutics Market, Distribution Channel Outlook (Revenue - USD Million, 2019 -2032)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Infantile Spasm Therapeutics Market, Region Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Infantile Spasm Therapeutics Market Insights

  • 4.1. Infantile Spasm Therapeutics - Industry Snapshot
  • 4.2. Infantile Spasm Therapeutics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising incidence of infantile spasms in newborns
      • 4.2.1.2. Increasing government supports
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of treatment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Infantile Spasm Therapeutics Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global Infantile Spasm Therapeutics Market, by Therapeutic Class

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
  • 5.3. Anticonvulsants
    • 5.3.1. Global Infantile Spasm Therapeutics Market, by Anticonvulsants, by Region, 2019-2032 (USD Million)
  • 5.4. Corticosteroids
    • 5.4.1. Global Infantile Spasm Therapeutics Market, by Corticosteroids, by Region, 2019-2032 (USD Million)
  • 5.5. Others
    • 5.5.1. Global Infantile Spasm Therapeutics Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Infantile Spasm Therapeutics Market, by Drug Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
  • 6.3. Vigabatrin
    • 6.3.1. Global Infantile Spasm Therapeutics Market, by Vigabatrin, by Region, 2019-2032 (USD Million)
  • 6.4. Adrenocorticotropic Hormone
    • 6.4.1. Global Infantile Spasm Therapeutics Market, by Adrenocorticotropic Hormone, by Region, 2019-2032 (USD Million)
  • 6.5. Others (Phase III)
    • 6.5.1. Global Infantile Spasm Therapeutics Market, by Others (Phase III), by Region, 2019-2032 (USD Million)

7. Global Infantile Spasm Therapeutics Market, by Dosage

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
  • 7.3. Solid
    • 7.3.1. Global Infantile Spasm Therapeutics Market, by Solid, by Region, 2019-2032 (USD Million)
  • 7.4. Liquid
    • 7.4.1. Global Infantile Spasm Therapeutics Market, by Liquid, by Region, 2019-2032 (USD Million)

8. Global Infantile Spasm Therapeutics Market, by Route of Administration

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
  • 8.3. Oral
    • 8.3.1. Global Infantile Spasm Therapeutics Market, by Oral, by Region, 2019-2032 (USD Million)
  • 8.4. Parenteral
    • 8.4.1. Global Infantile Spasm Therapeutics Market, by Parenteral, by Region, 2019-2032 (USD Million)
  • 8.5. Others
    • 8.5.1. Global Infantile Spasm Therapeutics Market, by Others, by Region, 2019-2032 (USD Million)

9. Global Infantile Spasm Therapeutics Market, by Distribution Channel

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • 9.3. Hospital Pharmacy
    • 9.3.1. Global Infantile Spasm Therapeutics Market, by Hospital Pharmacy, by Region, 2019-2032 (USD Million)
  • 9.4. Retail Pharmacy
    • 9.4.1. Global Infantile Spasm Therapeutics Market, by Retail Pharmacy, by Region, 2019-2032 (USD Million)
  • 9.5. Online Pharmacy
    • 9.5.1. Global Infantile Spasm Therapeutics Market, by Online Pharmacy, by Region, 2019-2032 (USD Million)

10. Global Infantile Spasm Therapeutics Market, by Geography

  • 10.1. Key findings
  • 10.2. Introduction
    • 10.2.1. Infantile Spasm Therapeutics Market Assessment, By Geography, 2019-2032 (USD Million)
  • 10.3. Infantile Spasm Therapeutics Market - North America
    • 10.3.1. North America: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
    • 10.3.2. North America: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
    • 10.3.3. North America: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
    • 10.3.4. North America: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
    • 10.3.5. North America: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.3.6. Infantile Spasm Therapeutics Market - U.S.
      • 10.3.6.1. U.S.: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.3.6.2. U.S.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.3.6.3. U.S.: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.3.6.4. U.S.: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.3.6.5. U.S.: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.3.7. Infantile Spasm Therapeutics Market - Canada
      • 10.3.7.1. Canada: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.3.7.2. Canada.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.3.7.3. Canada: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.3.7.4. Canada: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.3.7.5. Canada: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • 10.4. Infantile Spasm Therapeutics Market - Europe
    • 10.4.1. Europe: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
    • 10.4.2. Europe.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
    • 10.4.3. Europe: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
    • 10.4.4. Europe: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
    • 10.4.5. Europe: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.4.6. Infantile Spasm Therapeutics Market - UK
      • 10.4.6.1. UK: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.4.6.2. UK.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.4.6.3. UK: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.4.6.4. UK: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.4.6.5. UK: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.4.7. Infantile Spasm Therapeutics Market - France
      • 10.4.7.1. France: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.4.7.2. France.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.4.7.3. France: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.4.7.4. France: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.4.7.5. France: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.4.8. Infantile Spasm Therapeutics Market - Germany
      • 10.4.8.1. Germany: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.4.8.2. Germany.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.4.8.3. Germany: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.4.8.4. Germany: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.4.8.5. Germany: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.4.9. Infantile Spasm Therapeutics Market - Italy
      • 10.4.9.1. Italy: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.4.9.2. Italy.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.4.9.3. Italy: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.4.9.4. Italy: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.4.9.5. Italy: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.4.10. Infantile Spasm Therapeutics Market - Spain
      • 10.4.10.1. Spain: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.4.10.2. Spain.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.4.10.3. Spain: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.4.10.4. Spain: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.4.10.5. Spain: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.4.11. Infantile Spasm Therapeutics Market - Netherlands
      • 10.4.11.1. Netherlands: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.4.11.2. Netherlands.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.4.11.3. Netherlands: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.4.11.4. Netherlands: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.4.11.5. Netherlands: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.4.12. Infantile Spasm Therapeutics Market - Russia
      • 10.4.12.1. Russia: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.4.12.2. Russia.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.4.12.3. Russia: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.4.12.4. Russia: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.4.12.5. Russia: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • 10.5. Infantile Spasm Therapeutics Market - Asia Pacific
    • 10.5.1. Asia Pacific: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
    • 10.5.2. Asia Pacific.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
    • 10.5.3. Asia Pacific: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
    • 10.5.4. Asia Pacific: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
    • 10.5.5. Asia Pacific: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.5.6. Infantile Spasm Therapeutics Market - China
      • 10.5.6.1. China: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.5.6.2. China.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.5.6.3. China: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.5.6.4. China: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.5.6.5. China: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.5.7. Infantile Spasm Therapeutics Market - India
      • 10.5.7.1. India: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.5.7.2. India.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.5.7.3. India: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.5.7.4. India: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.5.7.5. India: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.5.8. Infantile Spasm Therapeutics Market - Japan
      • 10.5.8.1. Japan: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.5.8.2. Japan.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.5.8.3. Japan: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.5.8.4. Japan: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.5.8.5. Japan: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.5.9. Infantile Spasm Therapeutics Market - Malaysia
      • 10.5.9.1. Malaysia: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.5.9.2. Malaysia.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.5.9.3. Malaysia: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.5.9.4. Malaysia: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.5.9.5. Malaysia: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.5.10. Infantile Spasm Therapeutics Market - Indonesia
      • 10.5.10.1. Indonesia: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.5.10.2. Indonesia.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.5.10.3. Indonesia: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.5.10.4. Indonesia: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.5.10.5. Indonesia: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.5.11. Infantile Spasm Therapeutics Market - South Korea
      • 10.5.11.1. South Korea: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.5.11.2. South Korea.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.5.11.3. South Korea: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.5.11.4. South Korea: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.5.11.5. South Korea: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • 10.6. Infantile Spasm Therapeutics Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
    • 10.6.2. Middle East & Africa: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
    • 10.6.3. Middle East & Africa: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
    • 10.6.4. Middle East & Africa: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
    • 10.6.5. Middle East & Africa: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.6.6. Infantile Spasm Therapeutics Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.6.6.2. Saudi Arabia.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.6.6.3. Saudi Arabia: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.6.6.4. Saudi Arabia: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.6.6.5. Saudi Arabia: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.6.7. Infantile Spasm Therapeutics Market - UAE
      • 10.6.7.1. UAE: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.6.7.2. UAE.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.6.7.3. UAE: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.6.7.4. UAE: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.6.7.5. UAE: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.6.8. Infantile Spasm Therapeutics Market - Israel
      • 10.6.8.1. Israel: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.6.8.2. Israel.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.6.8.3. Israel: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.6.8.4. Israel: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.6.8.5. Israel: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.6.9. Infantile Spasm Therapeutics Market - South Africa
      • 10.6.9.1. South Africa: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.6.9.2. South Africa.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.6.9.3. South Africa: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.6.9.4. South Africa: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.6.9.5. South Africa: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
  • 10.7. Infantile Spasm Therapeutics Market - Latin America
    • 10.7.1. Latin America: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
    • 10.7.2. Latin America.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
    • 10.7.3. Latin America: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
    • 10.7.4. Latin America: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
    • 10.7.5. Latin America: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.7.6. Infantile Spasm Therapeutics Market - Mexico
      • 10.7.6.1. Mexico: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.7.6.2. Mexico.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.7.6.3. Mexico: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.7.6.4. Mexico: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.7.6.5. Mexico: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.7.7. Infantile Spasm Therapeutics Market - Brazil
      • 10.7.7.1. Brazil: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.7.7.2. Brazil.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.7.7.3. Brazil: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.7.7.4. Brazil: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.7.7.5. Brazil: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)
    • 10.7.8. Infantile Spasm Therapeutics Market - Argentina
      • 10.7.8.1. Argentina: Infantile Spasm Therapeutics Market, by Therapeutic Class, 2019-2032 (USD Million)
      • 10.7.8.2. Argentina.: Infantile Spasm Therapeutics Market, by Route of Administration, 2019-2032 (USD Million)
      • 10.7.8.3. Argentina: Infantile Spasm Therapeutics Market, by Drug Type, 2019-2032 (USD Million)
      • 10.7.8.4. Argentina: Infantile Spasm Therapeutics Market, by Dosage, 2019-2032 (USD Million)
      • 10.7.8.5. Argentina: Infantile Spasm Therapeutics Market, by Distribution Channel, 2019-2032 (USD Million)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Lundbeck
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Mallinckrodt Pharmaceuticals
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Catalyst Pharmaceuticals
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. GW Pharmaceuticals
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Retrophin
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Valerion Therapeutics
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Orphelia Pharma
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Insys Therapeutics
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Anavex Life Sciences Corp
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development